<SEC-DOCUMENT>0001193125-21-084201.txt : 20210317
<SEC-HEADER>0001193125-21-084201.hdr.sgml : 20210317
<ACCEPTANCE-DATETIME>20210317170829
ACCESSION NUMBER:		0001193125-21-084201
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20210317
DATE AS OF CHANGE:		20210317
EFFECTIVENESS DATE:		20210317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Praxis Precision Medicines, Inc.
		CENTRAL INDEX KEY:			0001689548
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-254410
		FILM NUMBER:		21751435

	BUSINESS ADDRESS:	
		STREET 1:		ONE BROADWAY
		STREET 2:		16TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-949-2220

	MAIL ADDRESS:	
		STREET 1:		ONE BROADWAY
		STREET 2:		16TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d620573ds8.htm
<DESCRIPTION>FORM S-8
<TEXT>
<HTML><HEAD>
<TITLE>Form S-8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on March 17, 2021 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration
<FONT STYLE="white-space:nowrap">No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">FORM&nbsp;S-8</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>PRAXIS PRECISION MEDICINES, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B><FONT STYLE="white-space:nowrap">47-5195942</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"><B>(State or other jurisdiction of<BR>incorporation or organization)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(I.R.S. Employer<BR>Identification No.)</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>One Broadway, 16th Floor</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cambridge, MA</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>02142</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"><B>(Address of Principal Executive Offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRAXIS PRECISION MEDICINES, INC. 2020 STOCK OPTION AND INCENTIVE PLAN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRAXIS PRECISION MEDICINES, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Full title of the plan) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Marcio Souza </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Chief
Executive Officer </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Praxis Precision Medicines, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>One Broadway, 16th Floor </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cambridge, MA 02142 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name
and address of agent for service) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">617-300-8460</FONT></FONT>
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Telephone number, including area code, of agent for service) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Copies to: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Richard A.
Hoffman, Esq. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>William D. Collins,&nbsp;Esq. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Goodwin Procter LLP </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>100
Northern Avenue </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Boston, Massachusetts 02210 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(617) <FONT STYLE="white-space:nowrap">570-1000</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated
filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company,&#148; and &#147;emerging growth company&#148; in <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2</FONT> of the Exchange Act. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated</FONT> filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging growth company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION
OF REGISTRATION FEE </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of Securities</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be Registered</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Registered(1)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering
Price</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>per Share</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Aggregate</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering Price</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Registration&nbsp;Fee</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock, $0.0001 par value per share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">1,913,427&nbsp;shares(2)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$44.11(3)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$84,401,264.97</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$9,208.18</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock, $0.0001 par value per share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">327,102 shares(4)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$37.49(5)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$12,263,053.98</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$1,337.90</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">2,240,529 shares</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$96,664,318.95</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$10,546.08</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), this
registration statement shall also cover any additional shares of common stock which become issuable under the Praxis Precision Medicines, Inc. 2020 Stock Option and Incentive Plan (the &#147;2020 Plan&#148;) and the Praxis Precision Medicines, Inc.
2020 Employee Stock Purchase Plan (the &#147;2020 ESPP&#148;) by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of
the Registrant&#146;s outstanding shares of common stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents an automatic increase of 1,913,427 shares of common stock to the number of shares available for
issuance under the 2020 Plan, effective January&nbsp;1, 2021. Shares available for issuance under the 2020 Plan were previously registered on a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> filed with the Securities
and Exchange Commission on October&nbsp;16, 2020 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-249522).</FONT> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The price of $44.11 per share, which is the average of the high and low sale prices of the common stock of the
registrant as quoted on the Nasdaq Global Select Market on March 12, 2021, is set forth solely for purposes of calculating the registration fee pursuant to Rules 457(c) and (h)&nbsp;of the Securities Act, and has been used as these shares are
without a fixed price. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents an automatic increase of 327,102 shares of common stock to the number of shares available for
issuance under the 2020 ESPP, effective January&nbsp;1, 2021. Shares available for issuance under the 2020 ESPP were previously registered on a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> filed with the Securities
and Exchange Commission on October&nbsp;16, 2020 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-249522).</FONT> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The price of $37.49 per share, which is 85% of the average of the high and low sale prices of the common stock
of the Registrant as quoted on the Nasdaq Global Select Market on March 12, 2021, is set forth solely for purposes of calculating the registration fee pursuant to Rules 457(c) and (h)&nbsp;of the Securities Act of 1933, as amended, and has been used
as these shares are without a fixed price. Pursuant to the 2020 ESPP, the purchase price of the shares of common stock reserved for issuance thereunder will be 85% of the fair market value of a share of common stock on the first trading day of the
offering period or on the exercise date, whichever is less. </P></TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> registers 1,913,427 additional shares of common stock under the Praxis
Precision Medicines, Inc. 2020 Stock Option and Incentive Plan (the &#147;2020 Plan&#148;) and 327,102 additional shares of common stock under the Praxis Precision Medicines, Inc. 2020 Employee Stock Purchase Plan (the &#147;2020 ESPP&#148;). The
number of shares of common stock reserved and available for issuance under the 2020 Plan is subject to an automatic annual increase on each January&nbsp;1, beginning in 2021, by an amount equal to five percent of the number of shares of common stock
issued and outstanding on the immediately preceding December&nbsp;31 or such lesser number of shares of common stock as determined by the Administrator (as defined in the 2020 Plan). Accordingly, on January&nbsp;1, 2021, the number of shares of
common stock reserved and available for issuance under the 2020 Plan increased by 1,913,427 shares. The number of shares of common stock reserved and available for issuance under the 2020 ESPP is subject to an automatic annual increase on each
January&nbsp;1, beginning in 2021, by the least of (i) 327,102 shares of common stock, (ii)&nbsp;an amount equal to one percent of the number of shares of common stock issued and outstanding on the immediately preceding December&nbsp;31 or
(iii)&nbsp;such lesser number of shares of common stock as determined by the Administrator (as defined in the 2020 ESPP). Accordingly, on January&nbsp;1, 2021, the number of shares of common stock reserved and available for issuance under the 2020
ESPP increased by 327,102 shares. The additional shares are of the same class as other securities relating to the 2020 Plan and the 2020 ESPP for which the Registrant&#146;s registration statement filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520271102/d45740ds8.htm">
<FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT></A> filed with the Securities and Exchange Commission on October&nbsp;16, 2020 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-249522),</FONT> is effective. The information contained in the
Registrant&#146;s registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520271102/d45740ds8.htm"><FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT></A> (Registration
<FONT STYLE="white-space:nowrap">No.&nbsp;333-249522)</FONT> is hereby incorporated by reference pursuant to General Instruction&nbsp;E. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Part II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Item&nbsp;8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exhibits. </B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520272877/d94620dex31.htm">Amended and Restated Certificate of Incorporation of the Registrant (Incorporated by reference to Exhibit 3.1 to the Registrant&#146;s Current
 Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-39620)</FONT> filed with the Securities and Exchange Commission on October&nbsp;20, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520272877/d94620dex32.htm">Amended and Restated Bylaws of the Registrant (Incorporated by reference to Exhibit 3.2 to the Registrant&#146;s Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-39620)</FONT> filed with the Securities and Exchange Commission on October&nbsp;20, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520266699/d945651dex41.htm">Specimen Common Stock Certificate of the Registrant (Incorporated by reference to Exhibit 4.1 to the Registrant&#146;s Registration Statement
 on Form <FONT STYLE="white-space:nowrap">S-1/A</FONT> (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-249074)</FONT> filed with the Securities and Exchange Commission on October&nbsp;9, 2020). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520254741/d945651dex42.htm">Fourth Amended and Restated Investors&#146; Rights Agreement by and among the Registrant and certain of its stockholders dated July&nbsp;
24, 2020 (Incorporated by reference to Exhibit 4.2 to the Registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;
333-249074)</FONT> filed with the Securities and Exchange Commission on September&nbsp;25, 2020). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;5.1*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d620573dex51.htm">Opinion of Goodwin Procter LLP.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">23.1*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d620573dex231.htm">Consent of Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">23.2*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d620573dex51.htm">Consent of Goodwin Procter LLP (included in Exhibit&nbsp;5.1). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">24.1*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Power of Attorney (included on signature page). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">99.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520266699/d945651dex104.htm">2020 Stock Option and Incentive Plan (Incorporated by reference to Exhibit 10.4 to the Registrant&#146;s Registration Statement on <FONT
STYLE="white-space:nowrap">Form&nbsp;S-1,</FONT> as amended (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-249074)</FONT> filed with the Securities and Exchange Commission on October&nbsp;9, 2020). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">99.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520266699/d945651dex105.htm">Form of Incentive Stock Option Agreement under the Registrant&#146;s 2020 Stock Option and Incentive Plan (Incorporated by reference to Exhibit
 10.5 to the Registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1,</FONT> as amended (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-249074)</FONT> filed with the Securities and Exchange Commission on
October&nbsp;9, 2020). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">99.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520266699/d945651dex106.htm">Form of <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option Agreement for Company Employees under the Registrant&#146;s 2020 Stock
 Option and Incentive Plan (Incorporated by reference to Exhibit 10.6 to the Registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1,</FONT> as amended (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-249074)</FONT>
filed with the Securities and Exchange Commission on October&nbsp;9, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">99.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520266699/d945651dex107.htm">Form of <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option Agreement for <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors
 under the Registrant&#146;s 2020 Stock Option and Incentive Plan (Incorporated by reference to Exhibit 10.7 to the Registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1,</FONT> as amended (File <FONT
STYLE="white-space:nowrap">No.&nbsp;333-249074)</FONT> filed with the Securities and Exchange Commission on October&nbsp;9, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">99.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520266699/d945651dex108.htm">Form of Restricted Stock Award Agreement under the Registrant&#146;s 2020 Stock Option and Incentive Plan (Incorporated by reference to Exhibit
 10.8 to the Registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1,</FONT> as amended (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-249074)</FONT> filed with the Securities and Exchange Commission on
October&nbsp;9, 2020). </A></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">99.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520266699/d945651dex109.htm">Form of Restricted Stock Award Agreement for Company Employees under the Registrant&#146;s 2020 Stock Option and Incentive Plan (Incorporated
 by reference to Exhibit 10.9 to the Registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1,</FONT> as amended (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-249074)</FONT> filed with the Securities and Exchange
Commission on October&nbsp;9, 2020). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">99.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520266699/d945651dex1010.htm">Form of Restricted Stock Award Agreement for <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors under the Registrant&#146;s 2020
 Stock Option and Incentive Plan (Incorporated by reference to Exhibit 10.10 to the Registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1,</FONT> as amended (File
<FONT STYLE="white-space:nowrap">No.&nbsp;333-249074)</FONT> filed with the Securities and Exchange Commission on October&nbsp;9, 2020). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">99.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1689548/000119312520266699/d945651dex1011.htm">2020 Employee Stock Purchase Plan (Incorporated by reference to Exhibit 10.11 to the Registrant&#146;s Registration Statement on Form <FONT
STYLE="white-space:nowrap">S-1,</FONT> as amended (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-240264)</FONT> filed with the Securities and Exchange Commission on October&nbsp;9, 2020)</A>.</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Filed herewith. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of
Cambridge, Commonwealth of Massachusetts, on March 17, 2021. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Praxis Precision Medicines, Inc.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/&nbsp;&nbsp;Marcio Souza</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marcio Souza</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY AND SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Marcio Souza and Alex Nemiroff,
and each of them, as such person&#146;s true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, with full power of substitution and resubstitution in each of them, for such person
in such person&#146;s, place and stead, in any and all capacities, to sign for us and in our names in the capacities indicated below the Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> of Praxis Precision Medicines,
Inc., and any or all amendments (including post-effective amendments), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in connection
therewith and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT>
and agents or any of them, or substitutes of any of them, may lawfully do or cause to be done by virtue hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the
requirements of the Securities Act of 1933, as amended, this Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> has been signed by the following persons in the capacities and on the dates indicated. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;&nbsp;Marcio Souza&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Marcio Souza</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Chief Executive Officer and Director<BR>(Principal Executive Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March 17, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;&nbsp;Lauren Mastrocola&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Lauren Mastrocola</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Principal Accounting Officer and <BR>Interim Principal Financial Officer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March 17, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;&nbsp;Dean Mitchell&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dean Mitchell</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Chairman of the Board</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March 17, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;&nbsp;Nicholas Galakatos&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Nicholas Galakatos, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March 17, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;&nbsp;Gregory Norden&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Gregory Norden</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March 17, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;&nbsp;Kiran Reddy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kiran Reddy, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March 17, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;&nbsp;Stefan Vitorovic &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Stefan Vitorovic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March 17, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;&nbsp;William Young &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">William Young</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March 17, 2021</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d620573dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">


<IMG SRC="g620573goodwin_logo.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Goodwin Procter <SMALL>LLP</SMALL></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">100&nbsp;Northern&nbsp;Avenue</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Boston, MA 02210</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">goodwinlaw.com</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">+1 617 570 1000</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">March&nbsp;17, 2021 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Praxis Precision Medicines, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One Broadway, 16th Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cambridge, MA 02142 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Securities Being Registered under Registration Statement on Form
<FONT STYLE="white-space:nowrap">S-8</FONT></U> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as counsel to you in connection with your filing of a
Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (the &#147;Registration Statement&#148;) pursuant to the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), on or about the date hereof relating to an
aggregate of (i) 1,913,427 shares (the &#147;Plan Shares&#148;) of common stock, $0.0001 par value per share (the &#147;Common Stock&#148;), of Precision Medicines, Inc., a Delaware corporation (the &#147;Company&#148;), that may be issued pursuant
to the Precision Medicines, Inc. 2020 Stock Option and Incentive Plan (the &#147;Incentive Plan&#148;) and (ii) 327,102 shares (the &#147;ESPP Shares&#148; and together with the Plan Shares, the &#147;Shares&#148;) of Common Stock of the Company
that may be issued pursuant to the Praxis Precision Medicines, Inc. 2020 Employee Stock Purchase Plan (the &#147;ESPP&#148; and, together with the Incentive Plan, the &#147;Plans&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have reviewed such documents and made such examination of law as we have deemed appropriate to give the opinion set forth below. We have
relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinion set forth below, on certificates of officers of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinion set forth below is limited to the Delaware General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the opinion set forth below, we have assumed that no event occurs that causes the number of authorized shares of Common Stock
available for issuance by the Company to be less than the number of then unissued Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the foregoing, we are of the opinion
that the Shares have been duly authorized and, upon issuance and delivery against payment therefor in accordance with the terms of the Plans, will be validly issued, fully paid and nonassessable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the inclusion of this opinion as Exhibit 5.1 to the Registration Statement. In giving our consent, we do not admit that
we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Very truly yours,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Goodwin Procter LLP</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GOODWIN PROCTER LLP</P></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d620573dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consent of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the incorporation by reference in the Registration Statement (Form <FONT STYLE="white-space:nowrap">S-8)</FONT> pertaining to the Praxis
Precision Medicines, Inc. 2020 Stock Option and Incentive Plan, and the Praxis Precision Medicines, Inc. 2020 Employee Stock Purchase Plan of our report dated March&nbsp;17, 2021, with respect to the consolidated financial statements of Praxis
Precision Medicines, Inc. included in its Annual Report (Form <FONT STYLE="white-space:nowrap">10-K)</FONT> for the year ended December&nbsp;31, 2020, filed with the Securities and Exchange Commission. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Ernst&nbsp;&amp; Young LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston, Massachusetts </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;17, 2021 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g620573goodwin_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g620573goodwin_logo.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( #8 ZP,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /WQ=RN_YL;20/F(QCM[&L'*K351R2C"[Y6WTZ=2HQE=*4'9
M[.*N[?B>,>/OCM\/OAXLD&L:ZMUJR(=FBZ4XOM1+$%E$T:.$L\XQF>2/V!Z'
MYS,^*LLRNE)5:SG6CO&+NT^RU/LN'N!.).)9QIY9E[>%5N>O53AR+:Z;6MO)
M,^(O'O[3GBWQE.D.A7&H>#]-@?,3:5K>J6^J3*#UNKFSN[>-@5.=@A^7;]YN
M*_(,\XRS'&U6\OQF+PE-NZ5/$5J>GI&<4?OW#'A-E61T^?,I8?.<0XZTL1AJ
M-6*EV2J0GMM>YV/PU_:?UC0(XM.\6Q7WB&PW*#J?]I7MSJ\(. QD_M"ZF2\'
M?:'M\<\FNW(?$',,K<:&;4ZN+H3^"O5K5*LK=WSRE^AXW%OA-#,?:XW)(T,%
M5CK+"T:-*C3BTM(Q5.,;;=GN?:O@_P")?A#QO )?#VN17,H4-)832^1?V^#@
M^=9RXD"AN-ZADXX8CFOU?*.(LIS9*6&QUJL=Z<I6U[6;/P;..'LVR.I*EF&
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M,NTMQ1^@E^1^I?PG^&?A_P"$7@70O GAF!H]-T6W*F>;:;K4+R9S-?:C>,H
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*:VT#F5B2M2#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
